tiprankstipranks
Amwell’s Q3 2024: Strategic Focus Amid Revenue Challenges
PremiumCompany AnnouncementsAmwell’s Q3 2024: Strategic Focus Amid Revenue Challenges
2M ago
Amwell reports Q3 EPS ($2.87), consensus ($3.40)
Premium
The Fly
Amwell reports Q3 EPS ($2.87), consensus ($3.40)
2M ago
Amwell sees FY24 revenue $247M-$252M, consensus $263.05M
Premium
The Fly
Amwell sees FY24 revenue $247M-$252M, consensus $263.05M
2M ago
Amwell price target lowered to $10 from $40 at Piper Sandler
PremiumThe FlyAmwell price target lowered to $10 from $40 at Piper Sandler
4M ago
Amwell price target lowered to $15 from $40 at Wells Fargo
Premium
The Fly
Amwell price target lowered to $15 from $40 at Wells Fargo
4M ago
Amwell rises 27.3%
Premium
The Fly
Amwell rises 27.3%
5M ago
Amwell price target raised to $12 from $2 at TD Cowen
PremiumThe FlyAmwell price target raised to $12 from $2 at TD Cowen
5M ago
Amwell sees FY24 revenue $259M-$269M consensus $261.53M
Premium
The Fly
Amwell sees FY24 revenue $259M-$269M consensus $261.53M
5M ago
Amwell reports Q2 EPS ($3.36), consensus ($3.97)
Premium
The Fly
Amwell reports Q2 EPS ($3.36), consensus ($3.97)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100